Clorox

At the conference, Clorox outlined a cautious growth plan targeting organic net sales growth of 3.5–4.5% for fiscal 2027 and named the ERP restart, selective pricing actions, productivity and the PURELL acquisition as drivers. Management expects near‑term pressure from persistent inflation (input costs > $200m), weak categories and a volatile first quarter, but sees benefits from ERP optimization toward late 2027/2028. CEO Linda Rendle announced her resignation; the company continues to emphasize investment in innovation, brands and operational efficiency, while some brands such as Fresh Step and Kingsford still face challenges. » Więcej na de.investing.com

Clorox reported sequential share improvements in FY2026 and expects muted category growth and timing-related headwinds in Q1 of FY2027, with a return to stronger trends in the back half of the year. Management completed its ERP implementation, plans to optimize the platform for productivity gains, and expects FY2027 inflation above $200 million with Brent assumptions around $90/bbl. The GOJO acquisition is performing ahead of plan, accretive to adjusted EPS and expected to drive mid- to high-single-digit growth and revenue synergies. Company guidance assumes targeted pricing and productivity offsets, elevated promotional activity versus pandemic levels, and continued investment in innovation and brand superiority to regain share in lagging businesses such as Litter. » Więcej na finance.yahoo.com

Clorox reported adjusted fourth-quarter earnings of 1.66 USD per share, slightly above expectations, and revenue of 1.95 billion USD. The acquisition of GOJO contributed about 10 percentage points to quarterly revenue, and the board modestly raised the quarterly dividend. For fiscal 2027, management expects net sales growth of 13–14%, but adjusted EPS of 5.70–6.00 USD is below consensus, while organic sales growth and gross margins are under pressure. This mixed outlook, along with margin concerns and a leadership change, limited pre-market gains. » Więcej na de.investing.com

Clorox reported adjusted Q4 2026 earnings of $1.66 per share and revenue of $1.95 billion, slightly above analyst expectations. The stock rose moderately, but management guided for flat to slightly positive organic sales growth and a gross margin of around 42% for fiscal 2027. The company expects raw-material inflation of more than $200 million and about $210 million in interest expense, while seeing market-share improvements across several brands and set to benefit from the completed ERP rollout and the acquisition of GOJO/Purell. Risks remain: high cost and competitive pressure and the announced CEO resignation. » Więcej na de.investing.com

Clorox will present results for the quarter ended June 30, 2026, on August 3, 2026. Fifteen analysts on average expect earnings per share of $1.64 versus $2.68 a year earlier; the revenue estimate (11 analysts) is $1.91 billion versus $1.99 billion previously. For the most recent fiscal year, 17 analysts see an average EPS of $5.52 (prior year $6.52) and 13 analysts forecast revenue of $6.68 billion versus $7.10 billion before. » Więcej na finanzen.net